The Limited Times

Now you can see non-English news...

Biontech, AstraZeneca and Co .: Hands off patents

2021-03-02T11:10:20.894Z

Politicians, doctors and economists want to force the pharmaceutical industry to release their vaccine formulas. But whoever removes patent protection is fighting the researchers, not the epidemic.



Icon: enlarge

Biontech founders Uğur Şahin and Özlem Türeci

Photo: Stefan F. Sämmer / imago images

There is hardly anything that the Germans are more in agreement about at the moment than in their jubilation over the Mainz entrepreneur couple Özlem Türeci and Uğur Şahin.

Your corona vaccine is considered the best weapon in the fight against the epidemic and your company is a flagship for Germany as a location for innovation.

Federal President Frank-Walter Steinmeier will soon award the two researchers the Federal Cross of Merit, and the "Bild" newspaper calls them, with unusual reverence, "our vaccination heroes".

Almost as popular at the moment, of course, is the demand to wrest one of the two researchers' most important tools: patent protection.

A broad alliance of politicians, physicians and non-governmental organizations supports the proposal by India and South Africa to release the exploitation rights to the vaccine formulas worldwide.

The World Trade Organization has stopped the plan for the time being, but it is by no means off the table.

In order to distribute the drugs fairly around the world, the Green Party leader Robert Habeck, for example, demands that the state must resort to compulsory licenses as part of an "emergency vaccine industry."

Read more with Spiegel Plus

More perspectives, more understanding.

Your advantages with SPIEGEL +

  • Icon: Check

    SPIEGEL as a magazine

    as an e-paper in the app and on the web

  • Icon: Check

    All articles on SPIEGEL.de

    exclusive texts for SPIEGEL + readers

  • Icon: Check

    Try one month for free

    can be canceled online at any time

One month for € 0.00

Try it now for € 0.00Arrow to the right

Already have a digital subscription? Register here

Read more with Spiegel Plus

More perspectives, more understanding.

Your advantages with SPIEGEL +

  • Icon: Check

    SPIEGEL as a magazine

    as an app and e-paper

  • Icon: Check

    All articles on SPIEGEL.de

    exclusive texts for SPIEGEL + readers

  • Icon: Check

    Only € 19.99 per month

    can be canceled at any time

Buy Now Right Arrow

Already have a digital subscription? Register here

Restore iTunes subscription

SPIEGEL + is processed via your iTunes account and paid for with a purchase confirmation.

24 hours before it expires, the subscription is automatically renewed for one month at the current price of 19.99 €

You can cancel the subscription at any time in the settings of your iTunes account.

In order to use SPIEGEL + outside of this app, you have to link the subscription to a SPIEGEL ID account immediately after purchase.

With the purchase you accept our general terms and conditions and privacy policy.

Source: spiegel

All business articles on 2021-03-02

You may like

Business 2021-02-01T12:08:20.713Z
Business 2021-02-08T02:34:42.216Z

Trends 24h

Business 2021-04-14T19:05:00.019Z

Latest

© Communities 2019 - Privacy